Personalis, Inc. (PSNL) vs Veracyte, Inc. (VCYT)
- Personalis, Inc. PSNL 15.81 +1.67%
- Veracyte, Inc. VCYT 24.14 +0.58%
Personalis, Inc. and Veracyte, Inc. are both Diagnostics & Research companies. Veracyte, Inc. is the larger, with a market value of $1.9B against $1.7B — 1.1× the size. Personalis, Inc. has negative trailing earnings, so its P/E is not meaningful; Veracyte, Inc. trades at 15.2×. Veracyte, Inc. grew revenue faster over the last twelve months: 17.5% against 16.9%. Veracyte, Inc. has the higher net margin (21.8% vs −147.7%) and the higher return on invested capital (4.33% vs −358.4%). Across the 17 metrics below, Veracyte, Inc. leads on 17 and Personalis, Inc. on 0.
Valuation
Profitability
| Metric | PSNL | VCYT | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 16.71% | 71.98% | 48.32% |
| Operating margin | (156.66%) | 17.08% | (5.68%) |
| Net margin | (147.74%) | 21.80% | (4.10%) |
| Free cash flow margin | (120.79%) | 27.84% | 0.00% |
| Return on equity | (62.14%) | 9.43% | 0.00% |
| Return on assets | (44.66%) | 8.63% | (6.05%) |
| Return on invested capital | (358.37%) | 4.33% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack